Filter by: Subject

Results Per Page:

Filter by: Subject

Acute myeloid leukaemia (AML) (1)
Africa (1)
AIDS-KS patients (1)
Anticoagulation practice (1)
Anticoagulation therapy (1)
Antiretroviral therapy (ART) (1)
Atrial fibrillation (AF) (1)
Breast cancer (1)
Cancer (1)
Cancer -- Treatment -- Complications (1)
Chronic myeloid leukaemia (CML) (1)
Chronic myeloid leukemia (CML) (1)
Chronic myeloid leukemia -- Treatment (1)
Chronic myeloid leukemia -- Treatment -- South Africa (1)
Combination of everolimus (1)
Current practice (1)
Diabetic angiopathies (1)
Diabetic patients (1)
First-line treatment (1)
HER2-positive early breast cancer (NeoALTTO) (1)
HIV-positive (1)
Human immunodeficiency virus (HIV) (2)
Hyperglycemia (1)
Imatinib (1)
Influenza-associated (1)
Kaposi’s sarcoma (KS) (1)
Lapatinib with trastuzumab (1)
Low-molecular-weight heparin (LMWH) (1)
Microscopy (1)
Multiple myeloma (MM) (1)
Myelodysplastic syndromes (MDS) (1)
Myelodysplastic syndromes -- South Africa (1)
NCCN (1)
Nilotinib (1)
Paclitaxel (1)
Pathological complete response (1)
Patients (1)
Prophylactic and therapeutic practice guideline (1)
Risk-factors (1)
Scanning electron microscopy (SEM) (1)
Severe acute respiratory illness (SARI) (1)
South Africa (1)
South Africa (SA) (1)
Southwest Oncology Group (SWOG) (1)
Spinal surgery (1)
Splenomegaly (1)
Surgery -- Complications (1)
Survival outcomes (1)
Thrombophlebitis (1)
Thromboprophylaxis (1)
Thrombosis (1)
Trastuzumab (1)
Treatment (1)
Vascular disease (1)
Venous thromboembolism (1)
Venous thromboembolism (VTE) (1)